The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors.
 
Taha Koray Sahin
No Relationships to Disclose
 
Deniz Can Guven
Honoraria - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Nobelpharma (Inst); Sandoz (Inst)
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb; Merck KGaA (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Eczacibasi (Inst); GlaxoSmithKline (Inst); MSD (Inst); Roche (Inst)
 
Mehmet I?cli?
No Relationships to Disclose
 
Latif Karahan
No Relationships to Disclose
 
Yunus Kaygusuz
No Relationships to Disclose
 
Zafer Arik
No Relationships to Disclose
 
Omer Dizdar
No Relationships to Disclose
 
Mustafa Erman
No Relationships to Disclose
 
Suayib Yalcin
Stock and Other Ownership Interests - Humana; Pfizer
Honoraria - Gen
Consulting or Advisory Role - Amgen; Bayer; bms; Gen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche
Speakers' Bureau - Bayer; Bayer; gen ilaç; Merck Serono; Novartis; Novartis; Pfizer; Roche
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Gen; Roche
 
Sercan Aksoy
Honoraria - AstraZeneca; Bristol Myers Squibb; Lilly; Merck, Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer